Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Oncology

Hepatology

Statin use reduced hepatocellular carcinoma risk in patients with NAFLD

Clinical Gastroenterology and Hepatology | Feb 15, 2022 Hepatology

Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: A single-arm, open-label, phase 2 trial

The Lancet: Gastroenterology & Hepatology | Feb 12, 2022 Hepatology

Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: A randomized, open-label, phase 2 trial

The Lancet: Gastroenterology & Hepatology | Feb 12, 2022 Hepatology

Risk of hepatocellular carcinoma in treatment-naïve chronic hepatitis B patients receiving tenofovir disoproxil fumarate vs entecavir in the United States

Alimentary Pharmacology and Therapeutics | Feb 11, 2022 Hepatology

Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: An individual patient data meta-analysis

Gut | Feb 10, 2022 Hepatology

Racial/ethnic disparities in hepatocellular carcinoma incidence and mortality rates in the United States, 1992-2018

Hepatology | Feb 09, 2022 Hepatology

Lower risk of HCC in chronic hepatitis B patients treated with tenofovir vs entecavir

Journal of Gastroenterology and Hepatology | Jan 28, 2022 Hepatology

Comparison of oncologic outcomes between open and laparoscopic distal pancreatectomy in pancreatic cancer

HPB | Jan 28, 2022 Hepatology

Declining disease burden of hepatocellular carcinoma in the US, 1992-2017: A population-based analysis

Hepatology | Jan 27, 2022 Hepatology

Statin use reduced hepatocellular carcinoma risk in patients with NAFLD

Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: A single-arm, open-label, phase 2 trial

Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: A randomized, open-label, phase 2 trial

Risk of hepatocellular carcinoma in treatment-naïve chronic hepatitis B patients receiving tenofovir disoproxil fumarate vs entecavir in the United States

Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: An individual patient data meta-analysis

Racial/ethnic disparities in hepatocellular carcinoma incidence and mortality rates in the United States, 1992-2018

Lower risk of HCC in chronic hepatitis B patients treated with tenofovir vs entecavir

Comparison of oncologic outcomes between open and laparoscopic distal pancreatectomy in pancreatic cancer

Declining disease burden of hepatocellular carcinoma in the US, 1992-2017: A population-based analysis

Gut Health Disorders and its Management

Autoimmune Disorders and its Management

Effect of Hypertension on eyes : MCQ Challenge

Forensic Medicine and Toxicology: An Introduction

MIP: HIV and Pulmonary System: HIV And Non Infectious Pulmonary Diseases: Dr Bhimasena Rao R S

Statin use reduced hepatocellular carcinoma risk in patients with NAFLD

Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: A single-arm, open-label, phase 2 trial

Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: A randomized, open-label, phase 2 trial

Risk of hepatocellular carcinoma in treatment-naïve chronic hepatitis B patients receiving tenofovir disoproxil fumarate vs entecavir in the United States

Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: An individual patient data meta-analysis

Racial/ethnic disparities in hepatocellular carcinoma incidence and mortality rates in the United States, 1992-2018

Lower risk of HCC in chronic hepatitis B patients treated with tenofovir vs entecavir

Comparison of oncologic outcomes between open and laparoscopic distal pancreatectomy in pancreatic cancer

Declining disease burden of hepatocellular carcinoma in the US, 1992-2017: A population-based analysis

Gut Health Disorders and its Management

Autoimmune Disorders and its Management

Effect of Hypertension on eyes : MCQ Challenge

Forensic Medicine and Toxicology: An Introduction

MIP: HIV and Pulmonary System: HIV And Non Infectious Pulmonary Diseases: Dr Bhimasena Rao R S

Select Specialty

Select Topic